Living definition
What is mFLUSIVA (Moderna mRNA-1010)?
Vaccines & Immunotherapy Bio, Health & Neuro
- As of
- 2026-08-20
- Revision
- 2026-08-17.1
- Method
- v1.3.0
Definition
The term, in context
AI-assisted draft · approved dataset
mFLUSIVA (Moderna mRNA-1010) is a messenger RNA-based seasonal influenza vaccine that uses lipid nanoparticle-encapsulated mRNA encoding hemagglutinin antigens from multiple influenza strains, prompting host cells to produce the viral proteins so the immune system can generate a protective antibody response, applying the same synthetic mRNA platform architecture used in other mRNA prophylactic vaccines to seasonal flu immunization.
Live readiness status
Status as of the current dateline
AI-assisted assembly · derived results
As of 2026-08-20, verified readiness is 75 (claimed 88, reported 84, gap 13) — Strong evidence strength; current signals suggest Adopt with guardrails.
The readiness fact belongs to the canonical Readiness Verdict for mFLUSIVA (Moderna mRNA-1010).
Dataset approval
Human editorial release
pragma.vision editorial — standing authorization (operator dev@soft.house, 2026-07-17)
- Dataset
- 2026-08-17.1
- Hash
- sha256:0c37108a182f510fc8cf4d1dfc3a30339f2b59e62654201edea2f530a268707e
- Approved
- 2026-08-17